{"id":"W4399395001","doi":"10.1200/jco.2024.42.16_suppl.5502","title":"Vibostolimab coformulated with pembrolizumab (vibo/pembro) for previously treated advanced mismatch repair–deficient (dMMR) endometrial cancer: Results from cohort B1 of the phase 2 KEYVIBE-005 study.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Kingston Health Sciences Centre","funders":"","keywords":"Medicine; Pembrolizumab; Endometrial cancer; Cohort; Cancer; Oncology; Internal medicine; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002534095,0.0009835145,0.001249235,0.0004709633,0.0004963396,0.001112235,0.0007259263,0.001116965,0.002968628],"category_scores_gemma":[0.001548431,0.0005421888,0.001346832,0.0004987243,0.0004138728,0.0007700854,0.0006140689,0.001669922,0.0009742884],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001066445,"about_ca_system_score_gemma":0.001524442,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002595796,"about_ca_topic_score_gemma":0.005219375,"domain_scores_codex":[0.9992531,0.0003618193,0.00004700541,0.0001241578,0.00008237507,0.0001314059],"domain_scores_gemma":[0.9988158,0.0001761098,0.0003114791,0.0001105324,0.00008800287,0.000498124],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7437121,0.03235001,0.09807631,0.001205981,0.006833291,0.0005467962,0.0004094949,0.002249568,0.02555784,0.0002065047,0.0140517,0.07480046],"study_design_scores_gemma":[0.3763195,0.3195193,0.264878,0.0003014102,0.005053359,0.001608936,0.0003668803,0.002150428,0.007246424,0.0003142096,0.02214134,0.0001003307],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9846539,0.003770525,0.0004700953,0.0002830676,0.00008430852,0.00186759,0.007280027,0.00004900846,0.001541551],"genre_scores_gemma":[0.9660074,0.00201155,0.001347853,0.001028859,0.000167077,0.002343672,0.0253629,0.00003594236,0.001694725],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002968628,"threshold_uncertainty_score":0.01340169,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09292514267589502,"score_gpt":0.4732235307505875,"score_spread":0.3802983880746925,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}